Bridges Investment Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$996K Hold
10,862
0.01% 258
2026
Q1
$926K Sell
10,862
-1,484
-12% -$132K 0.01% 246
2025
Q4
$976K Hold
12,346
0.01% 237
2025
Q3
$987K Sell
12,346
-29
-0.2% -$2.47K 0.01% 242
2025
Q2
$1.12M Buy
12,375
+9
+0.1% +$822 0.02% 232
2025
Q1
$1.16M Sell
12,366
-795
-6% -$71.2K 0.02% 220
2024
Q4
$1.2M Buy
13,161
+299
+2% +$28.5K 0.02% 187
2024
Q3
$1.34M Buy
12,862
+25
+0.2% +$2.55K 0.02% 174
2024
Q2
$1.25M Buy
12,837
+1,300
+11% +$120K 0.02% 170
2024
Q1
$1.04M Sell
11,537
-100
-0.9% -$8.47K 0.03% 136
2023
Q4
$928K Sell
11,637
-1,000
-8% -$75.2K 0.03% 137
2023
Q3
$899K Sell
12,637
-350
-3% -$26.2K 0.03% 137
2023
Q2
$1M Sell
12,987
-817
-6% -$63.2K 0.03% 134
2023
Q1
$1.04M Sell
13,804
-672
-5% -$50K 0.04% 140
2022
Q4
$1.14M Sell
14,476
-700
-5% -$52.5K 0.04% 136
2022
Q3
$1.07M Sell
15,176
-1,011
-6% -$79.3K 0.04% 138
2022
Q2
$1.3M Sell
16,187
-400
-2% -$31.3K 0.05% 136
2022
Q1
$1.26M Sell
16,587
-800
-5% -$63.4K 0.04% 140
2021
Q4
$1.49M Sell
17,387
-14,950
-46% -$1.17M 0.04% 135
2021
Q3
$2.44M Sell
32,337
-2,950
-8% -$234K 0.08% 114
2021
Q2
$2.87M Sell
35,287
-700
-2% -$57.2K 0.09% 102
2021
Q1
$2.84M Sell
35,987
-4,250
-11% -$333K 0.08% 103
2020
Q4
$3.44M Sell
40,237
-1,800
-4% -$149K 0.11% 91
2020
Q3
$3.24M Sell
42,037
-700
-2% -$53.4K 0.11% 92
2020
Q2
$3.13M Sell
42,737
-640
-1% -$45.5K 0.11% 93
2020
Q1
$2.88M Sell
43,377
-3,777
-8% -$266K 0.13% 98
2019
Q4
$3.25M Sell
47,154
-13,340
-22% -$910K 0.12% 105
2019
Q3
$4.45M Sell
60,494
-790
-1% -$57.3K 0.17% 93
2019
Q2
$4.39M Sell
61,284
-2,306
-4% -$164K 0.17% 91
2019
Q1
$4.36M Sell
63,590
-13,287
-17% -$858K 0.18% 93
2018
Q4
$4.58M Buy
76,877
+7,930
+12% +$496K 0.22% 84
2018
Q3
$4.62M Buy
68,947
+4,626
+7% +$308K 0.23% 87
2018
Q2
$4.17M Sell
64,321
-875
-1% -$57.2K 0.19% 94
2018
Q1
$4.67M Buy
65,196
+37,481
+135% +$2.7M 0.21% 88
2017
Q4
$2.09M Buy
27,715
+2,765
+11% +$202K 0.17% 89
2017
Q3
$1.82M Buy
24,950
+8,600
+53% +$620K 0.17% 78
2017
Q2
$1.21M Sell
16,350
-267
-2% -$19.8K 0.16% 79
2017
Q1
$1.22M Sell
16,617
-4,024
-19% -$282K 0.17% 79
2016
Q4
$1.35M Sell
20,641
-216
-1% -$14.8K 0.19% 78
2016
Q3
$1.54M Hold
20,857
0.26% 72
2016
Q2
$1.53M Buy
20,857
+2,224
+12% +$158K 0.26% 74
2016
Q1
$1.32M Buy
18,633
+167
+0.9% +$11.1K 0.24% 74
2015
Q4
$1.23M Sell
18,466
-517
-3% -$34.4K 0.22% 73
2015
Q3
$1.24M Hold
18,983
0.22% 74
2015
Q2
$1.24M Buy
18,983
+183
+1% +$12.4K 0.22% 74
2015
Q1
$1.3M Hold
18,800
0.23% 69
2014
Q4
$1.3M Buy
18,800
+50
+0.3% +$3.38K 0.23% 73
2014
Q3
$1.22M Buy
18,750
+800
+4% +$52.8K 0.23% 75
2014
Q2
$1.22M Buy
17,950
+65
+0.4% +$4.36K 0.23% 74
2014
Q1
$1.16M Buy
17,885
+1,176
+7% +$74.1K 0.24% 72
2013
Q4
$1.09M Buy
16,709
+925
+6% +$59.2K 0.25% 70
2013
Q3
$936K Buy
15,784
+7,866
+99% +$466K 0.23% 73
2013
Q2
$454K Buy
+7,918
New +$470K 0.12% 93

Other funds holding CL

Bridges Investment Management's CL Position: Q2 2026 in Review

Bridges Investment Management held its Colgate-Palmolive (CL) position steady in Q2 2026 at 10,862 shares worth $996K. The position accounts for 0.01% of the portfolio, ranked #258.

Bridges Investment Management first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.67M in Q1 2018. 1,245 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Bridges Investment Management held 10,862 shares of Colgate-Palmolive worth $996K as of Q2 2026.
  • Bridges Investment Management left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.01% of Bridges Investment Management's portfolio in Q2 2026, its #258 holding.
  • Bridges Investment Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Bridges Investment Management's Colgate-Palmolive position peaked at $4.67M in Q1 2018.
  • 1,245 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Bridges Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.